Form 4 · Statement of Changes in Beneficial Ownership · Filed 2026-08-06
Casper Marc N Files Thermo Fisher Scientific (TMO) Form 4 - August 06, 2026
Casper Marc N traded 25.0K TMO shares worth $11.7M in this Form 4 filing, reported to the SEC on 2026-08-06.
- Insider
- Casper Marc N
- Issuer
- Thermo Fisher Scientific Inc. TMO · NYSE
- Filed
- Period
- 2026-08-06
- Accession
- 0001216055-26-000007
- Source
- Official filing on sec.gov ↗
Transactions (20)
| Insider | Date | Type | Shares | Price | Value | Own |
|---|---|---|---|---|---|---|
| Casper Marc N | 2026-08-06 | Buy | 10.0K | $309.63 | $3.1M | Direct |
| Casper Marc N | 2026-08-06 | Sell | 480 | $571.05 | $274.1K | Direct |
| Casper Marc N | 2026-08-06 | Sell | 1.6K | $572.43 | $933.6K | Direct |
| Casper Marc N | 2026-08-06 | Sell | 2.5K | $573.53 | $1.5M | Direct |
| Casper Marc N | 2026-08-06 | Sell | 1.6K | $574.40 | $928.8K | Direct |
| Casper Marc N | 2026-08-06 | Sell | 2.2K | $575.46 | $1.2M | Direct |
| Casper Marc N | 2026-08-06 | Sell | 480 | $576.46 | $276.7K | Direct |
| Casper Marc N | 2026-08-06 | Sell | 451 | $577.43 | $260.4K | Direct |
| Casper Marc N | 2026-08-06 | Sell | 321 | $578.67 | $185.8K | Direct |
| Casper Marc N | 2026-08-06 | Sell | 311 | $579.90 | $180.3K | Direct |
| Casper Marc N | 2026-08-06 | Sell | 240 | $571.00 | $137.0K | Indirect |
| Casper Marc N | 2026-08-06 | Sell | 660 | $572.33 | $377.7K | Indirect |
| Casper Marc N | 2026-08-06 | Sell | 1.2K | $573.34 | $688.0K | Indirect |
| Casper Marc N | 2026-08-06 | Sell | 1.0K | $574.28 | $578.9K | Indirect |
| Casper Marc N | 2026-08-06 | Sell | 1.1K | $575.41 | $609.9K | Indirect |
| Casper Marc N | 2026-08-06 | Sell | 225 | $576.09 | $129.6K | Indirect |
| Casper Marc N | 2026-08-06 | Sell | 361 | $577.57 | $208.5K | Indirect |
| Casper Marc N | 2026-08-06 | Sell | 119 | $578.93 | $68.9K | Indirect |
| Casper Marc N | 2026-08-06 | Sell | 127 | $580.01 | $73.7K | Indirect |
| Net change | −5.0K | −$5.5M | ||||
About Thermo Fisher Scientific Inc.
Thermo Fisher Scientific Inc. is a world-leading biotechnology company that provides essential tools and services for life sciences, biotechnology, pharmaceutical, and healthcare industries. Renowned for its extensive portfolio, the company specializes in offering innovative laboratory products, analytical instruments, and software solutions critical for research, diagnostics, and clinical applications. Thermo Fisher enables scientists to perform complex experiments with cutting-edge technology, from DNA sequencing and cell analysis to clinical diagnostics and specialty chemicals. Serving a vast array of sectors, the company impacts fields such as diagnostics, genetic engineering, and environmental monitoring. Its strategic acquisitions and collaborations strengthen its market presence, making it a go-to partner for scientific advancements and innovation. With operations spanning over 50 countries, Thermo Fisher plays a pivotal role in driving scientific discovery and improving health outcomes globally.
Track TMO insider activity
Get alerted when Thermo Fisher Scientific Inc. executives buy or sell their shares.